French-Canadian biotech Domain Therapeutics has another big pharma partner, signing a deal with Germany's Boehringer Ingelheim to develop new ... read more
Boehringer inks pact with Domain for GPCR neurology drugs
Boehringer inks pact with Domain for GPCR neurology drugs